Whats new
Whats new.
CLSA - Head & neck take two: Hopeful on durability data at ESMO, may support positive outlook; Retain Outperform, A$0.95 PT (Analyst: Andrew Paine)
September 11th 2024
For a copy of this research report please contact your CLSA advisor